Medical Properties Trust (NYSE:MPW) Lowered to C+ at TheStreet

Medical Properties Trust (NYSE:MPWGet Rating) was downgraded by TheStreet from a “b-” rating to a “c+” rating in a research report issued on Wednesday, TheStreetRatingsTable reports.

Other equities analysts have also recently issued reports about the stock. Truist Financial reduced their price target on shares of Medical Properties Trust from $26.00 to $23.00 and set a “hold” rating on the stock in a research report on Thursday, March 24th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Medical Properties Trust from $25.00 to $20.00 in a report on Wednesday, April 27th. StockNews.com upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, May 23rd. Jefferies Financial Group lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $25.00 to $20.00 in a report on Friday, April 22nd. Finally, Bank of America lowered shares of Medical Properties Trust from a “buy” rating to a “neutral” rating and set a $21.00 price objective on the stock. in a report on Friday, March 11th. Four analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $23.13.

Shares of MPW stock opened at $14.34 on Wednesday. Medical Properties Trust has a 52-week low of $14.28 and a 52-week high of $24.13. The stock has a market cap of $8.61 billion, a PE ratio of 7.67, a PEG ratio of 0.82 and a beta of 0.65. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.64 and a current ratio of 1.64. The firm’s 50 day moving average price is $18.37 and its two-hundred day moving average price is $20.56.

Medical Properties Trust (NYSE:MPWGet Rating) last announced its quarterly earnings data on Thursday, April 28th. The real estate investment trust reported $1.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.58. The firm had revenue of $409.80 million for the quarter, compared to analysts’ expectations of $413.31 million. Medical Properties Trust had a net margin of 70.61% and a return on equity of 13.25%. The business’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same period last year, the firm earned $0.42 earnings per share. As a group, sell-side analysts predict that Medical Properties Trust will post 1.83 earnings per share for the current fiscal year.

In other news, CEO Edward K. Aldag, Jr. sold 615,000 shares of the company’s stock in a transaction dated Wednesday, March 30th. The shares were sold at an average price of $21.33, for a total value of $13,117,950.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO R Steven Hamner sold 285,000 shares of the company’s stock in a transaction dated Thursday, April 7th. The shares were sold at an average price of $21.04, for a total transaction of $5,996,400.00. Following the completion of the sale, the chief financial officer now directly owns 1,961,214 shares in the company, valued at $41,263,942.56. The disclosure for this sale can be found here. 1.04% of the stock is currently owned by insiders.

Several hedge funds have recently modified their holdings of MPW. Northwestern Mutual Investment Management Company LLC raised its holdings in Medical Properties Trust by 0.5% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 98,849 shares of the real estate investment trust’s stock valued at $2,336,000 after acquiring an additional 445 shares during the period. Koshinski Asset Management Inc. grew its position in shares of Medical Properties Trust by 13.5% during the 4th quarter. Koshinski Asset Management Inc. now owns 3,802 shares of the real estate investment trust’s stock worth $90,000 after purchasing an additional 451 shares in the last quarter. Dupont Capital Management Corp grew its position in shares of Medical Properties Trust by 0.6% during the 4th quarter. Dupont Capital Management Corp now owns 83,991 shares of the real estate investment trust’s stock worth $1,985,000 after purchasing an additional 466 shares in the last quarter. Lazard Asset Management LLC grew its position in shares of Medical Properties Trust by 2.2% during the 4th quarter. Lazard Asset Management LLC now owns 22,015 shares of the real estate investment trust’s stock worth $519,000 after purchasing an additional 466 shares in the last quarter. Finally, Redpoint Investment Management Pty Ltd grew its position in shares of Medical Properties Trust by 0.8% during the 4th quarter. Redpoint Investment Management Pty Ltd now owns 57,332 shares of the real estate investment trust’s stock worth $1,355,000 after purchasing an additional 478 shares in the last quarter. 82.27% of the stock is currently owned by institutional investors.

Medical Properties Trust Company Profile (Get Rating)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.

Featured Stories

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Want More Great Investing Ideas?

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.